Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genes and Immunity is Scopus-indexed (Q2, CiteScore 5.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Nature.
Checked against the index lists dated .
ISSN 1466-4879Verify ISSN ↗1476-5470Verify ISSN ↗
Publisher: Springer Nature
Cost to publish: About US$3,190 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 31 / 100 | 69th | Q2 |
| Genetics | 120 / 357 | 66th | Q2 |
| Immunology | 97 / 243 | 60th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present (also 1999–2017), best quartile Q2, CiteScore 5.9.
Genes and Immunity is Q2 in Genetics (clinical) (rank 31 of 100), Q2 in Genetics (rank 120 of 357) and Q2 in Immunology (rank 97 of 243), by CiteScore 2025.
Genes and Immunity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.344, quartile Q1, with an H-index of 117.
The publisher lists an article processing charge of about US$3,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Genes and Immunity is published by Springer Nature. Its print ISSN is 1466-4879 and its online ISSN is 1476-5470.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Genes and Immunity has an h-index of 127 and a 2-year mean of 3.78 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q2. On 2-year citations it ranks #17 of 99 Scopus journals in Genetics (clinical).
Genes and Immunity published 56 papers in 2025; its busiest recent year was 2024 with 68. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from China (53%), United States (15.5%) and France (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.